TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nec Oncoimmunity AS
Closing information (x1000 DKK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
26,518
|
28,720
|
2,119 |
| Financial expenses |
987
|
1,427
|
1,580 |
| Earnings before taxes |
-44,385
|
-28,686
|
-23,932 |
| Total assets |
47,755
|
55,976
|
48,033 |
| Current assets |
44,030
|
52,089
|
42,939 |
| Current liabilities |
18,831
|
26,868
|
8,145 |
| Equity capital |
28,925
|
29,108
|
39,888 |
| - share capital |
254
|
237
|
231 |
| Employees (average) | 18 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
60.6%
|
52.0%
|
83.0% |
| Turnover per employee | 118 | ||
| Profit as a percentage of turnover |
-167.4%
|
-99.9%
|
-1129.4% |
| Return on assets (ROA) |
-90.9%
|
-48.7%
|
-46.5% |
| Current ratio |
233.8%
|
193.9%
|
527.2% |
| Return on equity (ROE) |
-153.4%
|
-98.6%
|
-60.0% |
| Change turnover |
-2,935
|
26,666
|
550 |
| Change turnover % |
-10%
|
1298%
|
35% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.